Lynn McRoy
Impact in
-
- Advanced Breast Cancer Therapies
- Cancer-related cognitive impairment studies
- Cardiovascular and Diving-Related Complications
-
- Breast Cancer Treatment Studies
Papers in
-
- Advanced Breast Cancer Therapies 35
-
- Breast Cancer Treatment Studies 6
- Co-authors
- Adam M. Brufsky (23 shared papers)Rachel M. Layman (18 shared papers)Xianchen Liu (15 shared papers)Hope S. Rugo (19 shared papers)Benjamin C. Li (18 shared papers)Richard S. Finn (4 shared papers)Angela M. DeMichele (6 shared papers)Massimo Cristofanilli (6 shared papers)
- Journals
- Annals of Oncology (7 papers)Future Oncology (5 papers)The Oncologist (3 papers)ESMO Open (3 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Lynn McRoy
39 papers receiving 666 citations
Lynn McRoy's Hit Papers
Peers
Comparison fields: 5 of 48
- Pulmonary and Respiratory Medicine 558
- Cancer Research 119
- Oncology 198
- Genetics 62
- Internal Medicine 13
Countries citing papers authored by Lynn McRoy
This map shows the geographic impact of Lynn McRoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn McRoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn McRoy more than expected).
Fields of papers citing papers by Lynn McRoy
This network shows the impact of papers produced by Lynn McRoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn McRoy. The network helps show where Lynn McRoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynn McRoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 127 | |
| 2 | 2021 | 93 | |
| 3 | 2022 | 78 | |
| 4 | 2018 | 55 | |
| 5 | 1991 | 28 | |
| 6 | 2021 | 28 | |
| 7 | 2020 | 26 | |
| 8 | 2021 | 25 | |
| 9 | Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world setting Hit paper breakdown → | 2025 | 23 |
| 10 | 2021 | 23 | |
| 11 | 2023 | 19 | |
| 12 | 2023 | 17 | |
| 13 | 2022 | 17 | |
| 14 | 2020 | 15 | |
| 15 | 2019 | 15 | |
| 16 | 2023 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2023 | 8 |
About Lynn McRoy
Lynn McRoy is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Economics and Econometrics and Genetics, having authored 40 papers that have together received 682 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (35 papers), Breast Cancer Treatment Studies (6 papers), Cancer-related Molecular Pathways (3 papers), Economic and Financial Impacts of Cancer (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (558 citations), Cancer Research (119 citations), Oncology (198 citations), Genetics (62 citations) and Internal Medicine (13 citations). Lynn McRoy has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Adam M. Brufsky, Rachel M. Layman, Xianchen Liu, Hope S. Rugo, Benjamin C. Li, Richard S. Finn, Angela M. DeMichele, Massimo Cristofanilli, Mylin Ann Torres and Connie Chen. Their work appears in journals such as Annals of Oncology, Future Oncology, The Oncologist, ESMO Open and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.